Evidence map›Paper›PMID 29058572›Full record

ArticleSubstance abuse2018

Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection.

Sara A Lorkiewicz, Alicia S Ventura, Timothy C Heeren, Michael R Winter, Alexander Y Walley, Meg Sullivan, Jeffrey H Samet, Richard Saitz

Abstract read
In one paragraph

Article in Substance abuse, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Neuroimaging the Neuropathogenesis of HIV.Current HIV/AIDS reports · 2021
    Review
  18. Reciprocal Influences of HIV and Cannabinoids on the Brain and Cognitive Function.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara A Lorkiewicza Graduate Medical Sciences, Boston University School of Medicine , Boston , Massachusetts , USA.
Alicia S Venturab Department of Community Health Sciences , Boston University School of Public Health , Boston , Massachusetts , USA.
Timothy C Heerenc Department of Biostatistics , Boston University School of Public Health , Boston , Massachusetts , USA.
Michael R Winterd Data Coordinating Center , Boston University School of Public Health , Boston , Massachusetts , USA.
Alexander Y Walleye Clinical Addiction Research and Education (CARE) Unit, Section of General Internal Medicine , Department of Medicine, Boston University School of Medicine and Boston Medical Center , Boston , Massachusetts , USA.
Meg Sullivanf Section of Infectious Diseases , Department of Medicine, Boston University School of Medicine and Boston Medical Center , Boston , Massachusetts , USA.
Jeffrey H Sametb Department of Community Health Sciences , Boston University School of Public Health , Boston , Massachusetts , USA.
Richard Saitzb Department of Community Health Sciences , Boston University School of Public Health , Boston , Massachusetts , USA.

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)U01AA020784 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HEEREN, TIMOTHY C., KIM, THERESA W · 2011 to 2021
$6.4M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
NCATS NIH HHS UL1 TR001430NIAAA NIH HHS U01 AA020784NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24 AA020779
6 · The paper itself

Abstract

backgroundSubstance use is common among people with human immunodeficiency virus (HIV) infection. Alcohol, marijuana, and HIV can have negative effects on cognition. Associations between current and lifetime marijuana and alcohol use and cognitive dysfunction in people with HIV infection were examined.

methodsSome 215 HIV-infected adults with Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) substance dependence or ever injection drug use were studied. In adjusted cross-sectional regression analyses associations were assessed between current marijuana use, current heavy alcohol use, lifetime marijuana use, lifetime alcohol use, duration of heavy alcohol use (the independent variables), and 3 measures of cognitive dysfunction (dependent variables): both the (i) memory and (ii) attention domains from the Montreal Cognitive Assessment (MoCA) and the (iii) 4-item cognitive function scale (CF4) from the Medical Outcomes Study HIV Health Survey (MOS-HIV). Analyses were adjusted for demographics, primary language, depressive symptoms, anxiety, comorbidities, antiretroviral therapy, hepatitis C virus (ever), duration of HIV infection (years), HIV-viral load (log copies/mL), CD4 cell count, lifetime and recent cocaine use, and recent illicit and prescribed opioid use.

resultsCurrent marijuana use was significantly and negatively associated with the MOS-HIV CF4 score (adjusted mean difference = -0.40, P = .01). Current marijuana use was not significantly associated with either MoCA score. Lifetime marijuana use and current heavy and lifetime alcohol use and duration of heavy alcohol use were not associated with any measure of cognitive dysfunction.

conclusionCurrent marijuana use was associated with one measure of cognitive dysfunction, but there was not a consistent pattern of association with lifetime marijuana use or alcohol use and measures of cognitive dysfunction. Understanding the mechanism by which marijuana, with and without alcohol, are associated with worse cognition warrants larger, longer studies with more precise and diverse measurements of cognitive function.

Indexed as

AdolescentAdultAlcohol DrinkingBostonCognitive DysfunctionComorbidityCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMarijuana SmokingMiddle AgedUncertaintyYoung AdultAlcoholcannabiscognitive functionethanolHIV infectionlifetimemarijuana

Identifiers

PMID29058572
PMCPMC5979270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.